Institutional Ownership
Acrivon Therapeutics Inc
CUSIP 004890109COMMON STOCKACRVQ1 2026
Institutional Holders
41
13F filers
Shares Held
15.40M
Aggregate institutional
Institutional Value
$19.97M
Q1 2026
Net New Holders
-5
7 new · 12 closed
Institutional Ownership Trend
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradePosition Activity
Q1 2026
New positions7
Increased11
Decreased11
Sold out12
Institutional Holders
41 funds hold this security · Q1 2026
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Ra Capital Management, L.P. | 8.34M | $11.59M | 0 | Held |
| 2 | Sands Capital Alternatives, LLC | 2.12M | $2.95M | 0 | Held |
| 3 | Wellington Management Group LLP | 888.1K | $1.23M | 0 | Held |
| 4 | Renaissance Technologies LLC | 758.4K | $1.05M | +124.3K | Added |
| 5 | Marshall Wace, LLP | 560.4K | $779.0K | +64.4K | Added |
| 6 | Two Sigma Investments, LP | 389.4K | $541.3K | −195.7K | Reduced |
| 7 | Jane Street Group, LLC | 239.7K | $333.2K | −102.4K | Reduced |
| 8 | Geode Capital Management, LLC | 236.4K | $328.7K | +38.2K | Added |
| 9 | Blackrock, Inc. | 208.9K | $290.4K | +3.8K | Added |
| 10 | Bridgeway Capital Management, LLC | 158.9K | $220.9K | +116.0K | Added |
31 more institutional holders on Premium
See every fund holding Acrivon Therapeutics Inc, with full quarter-over-quarter share changes.
Unlock all holders